Skip to main content
. 2022 Feb 4;23(3):1799. doi: 10.3390/ijms23031799

Table 3.

Anti-bacterial activity of the synthesized AgNPs.

Treatments ZOI (mm)
S. aureus MRSA S. epidermidis K. pneumoniae E. coli
MHB 0 0 0 0 0
GAE 0 0 0 0 0
C-AgNPs 9.8 9.8 8.4 11 6.2
GAC-AgNPs 0 0 0 0 0
GA-AgNPs_0.4g 14.2 13.8 20 13.6 11.2
GA-AgNPs_0.5g 13 9.8 19 14.6 10.2